1. Home
  2. TRVN

TRVN

Trevena Inc.

Logo Trevena Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 3:59pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.

Founded: 2007 Country:
United States
United States
Employees: N/A City: CHESTERBROOK
Market Cap: 7.4M IPO Year: 2014
Target Price: $2.00 AVG Volume (30 days): 125.4K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.16 EPS Growth: N/A
52 Week Low/High: $0.30 - $3.28 Next Earning Date: 05-13-2024
Revenue: $3,125,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: